Slide 1 NSABP PROTOCOL C-10: RESULTS A Phase II Trial of 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) Plus Bevacizumab for Patients with Unresectable Stage IV Colon…
Greg Yothers, Stephanie R. Land, Clifford Y. Ko, D. Lawrence Wickerham, Louis Fehrenbacher, Jeffrey K. Giguere, Norman Wolmark, and Patricia A. Ganz Neurotoxicity is an important…
Emerging Paradigms in the Multimodality Treatment of Locally Advanced Rectal Cancer A. William Blackstock, Jr., MD Wake Forest University Comprehensive Cancer Center Case…
A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07 N. Wolmark, S. Wieand, P. J. Kuebler,…
A Phase III Trial Comparing FULV to FULV + Oxaliplatin in Stage II or III Carcinoma of the Colon: Results of NSABP-C-07 Norman Wolmark, MD Colorectal Cancer Update Think…
NSABP PROTOCOL B-39 RTOG PROTOCOL 0413 A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with…
Greg Yothers, Stephanie R. Land, Clifford Y. Ko, D. Lawrence Wickerham, Louis Fehrenbacher, Jeffrey K. Giguere, Norman Wolmark, and Patricia A. Ganz Neurotoxicity is an important…
Emerging Paradigms in the Multimodality Treatment of Locally Advanced Rectal Cancer A. William Blackstock, Jr., MD Wake Forest University Comprehensive Cancer Center Case…